Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor-Positive Advanced Breast Cancer
Saved in:
Published in | Journal of clinical oncology Vol. 28; no. 30; pp. 4594 - 4600 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Russian |
Published |
Alexandria, VA
American Society of Clinical Oncology
2010
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0732-183X 1527-7755 |
---|